These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29208771)

  • 1. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
    Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
    Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.
    Das SK; Wang W; Zhabyeyev P; Basu R; McLean B; Fan D; Parajuli N; DesAulniers J; Patel VB; Hajjar RJ; Dyck JR; Kassiri Z; Oudit GY
    Sci Rep; 2015 Dec; 5():18132. PubMed ID: 26638758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.
    Wongjaikam S; Kumfu S; Khamseekaew J; Chattipakorn SC; Chattipakorn N
    Sci Rep; 2017 Mar; 7():44460. PubMed ID: 28287621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.
    Oudit GY; Sun H; Trivieri MG; Koch SE; Dawood F; Ackerley C; Yazdanpanah M; Wilson GJ; Schwartz A; Liu PP; Backx PH
    Nat Med; 2003 Sep; 9(9):1187-94. PubMed ID: 12937413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload.
    Das SK; DesAulniers J; Dyck JR; Kassiri Z; Oudit GY
    Liver Int; 2016 Feb; 36(2):246-57. PubMed ID: 26077449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
    Zhabyeyev P; Das SK; Basu R; Shen M; Patel VB; Kassiri Z; Oudit GY
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H978-H990. PubMed ID: 29373036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications.
    Zhabyeyev P; Sadasivan C; Shah S; Wang F; Oudit GY
    Front Cardiovasc Med; 2023; 10():1129349. PubMed ID: 37153462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.
    Sulaiman M; Matta MJ; Sunderesan NR; Gupta MP; Periasamy M; Gupta M
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H833-43. PubMed ID: 20008278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    Expert Rev Hematol; 2018 Jun; 11(6):471-479. PubMed ID: 29754517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte neogenin is required for hemojuvelin-mediated hepcidin expression and iron homeostasis in mice.
    Enns CA; Jue S; Zhang AS
    Blood; 2021 Aug; 138(6):486-499. PubMed ID: 33824974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload.
    Brewer CJ; Wood RI; Wood JC
    Exp Hematol; 2014 Dec; 42(12):1059-67. PubMed ID: 25220979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C57BL/6 genetic background confers cardioprotection in iron-overloaded mice.
    Musumeci M; Maccari S; Sestili P; Massimi A; Corritore E; Marano G; Catalano L
    Blood Transfus; 2013 Jan; 11(1):88-93. PubMed ID: 22790263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.
    Parajuli N; Patel VB; Wang W; Basu R; Oudit GY
    Clin Sci (Lond); 2014 Sep; 127(5):331-40. PubMed ID: 24624929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin ameliorates iron-overload cardiomyopathy through the PPARα-PGC-1-dependent signaling pathway.
    Lin H; Lian WS; Chen HH; Lai PF; Cheng CF
    Mol Pharmacol; 2013 Aug; 84(2):275-85. PubMed ID: 23723143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.
    Moon SN; Han JW; Hwang HS; Kim MJ; Lee SJ; Lee JY; Oh CK; Jeong DC
    Pediatr Cardiol; 2011 Oct; 32(7):947-52. PubMed ID: 21656238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duality of Nrf2 in iron-overload cardiomyopathy.
    Federti E; Vinchi F; Iatcenko I; Ghigo A; Matte A; Toya SCM; Siciliano A; Chiabrando D; Tolosano E; Vance SZ; Riccardi V; Andolfo I; Iezzi M; Lamolinara A; Iolascon A; De Franceschi L
    Haematologica; 2023 May; 108(5):1335-1348. PubMed ID: 36700398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of juvenile hemochromatosis.
    Huang FW; Pinkus JL; Pinkus GS; Fleming MD; Andrews NC
    J Clin Invest; 2005 Aug; 115(8):2187-91. PubMed ID: 16075059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.